PubRank

Stephen M Strittmatter

Author PubWeight™ 143.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009 6.99
2 Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003 4.23
3 Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005 4.15
4 Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 2002 3.50
5 Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 2010 3.44
6 Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010 3.36
7 An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 2009 3.34
8 Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002 3.33
9 Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012 2.92
10 Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003 2.76
11 Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004 2.76
12 Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 2004 2.67
13 A new role for Nogo as a regulator of vascular remodeling. Nat Med 2004 2.63
14 Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 2004 2.29
15 Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci 2006 2.28
16 Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 2003 2.23
17 RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol 2004 2.14
18 The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci 2003 2.11
19 Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 2006 2.10
20 Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci 2002 2.01
21 Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002 1.96
22 Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci 2008 1.96
23 Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 2007 1.88
24 Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron 2013 1.87
25 MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci 2010 1.86
26 Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J 2003 1.78
27 The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci 2006 1.77
28 Neogenin mediates the action of repulsive guidance molecule. Nat Cell Biol 2004 1.77
29 Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci 2008 1.66
30 Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci 2010 1.66
31 Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 2007 1.64
32 The reticulons: a family of proteins with diverse functions. Genome Biol 2007 1.62
33 Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci 2002 1.55
34 Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci 2003 1.52
35 Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol 2006 1.44
36 The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol 2007 1.43
37 Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci 2005 1.43
38 Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 2010 1.42
39 Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci U S A 2006 1.39
40 The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci 2008 1.38
41 ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist 2007 1.38
42 Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ 2009 1.37
43 LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci 2009 1.32
44 Structural bases for CRMP function in plexin-dependent semaphorin3A signaling. EMBO J 2003 1.29
45 Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke 2010 1.25
46 Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov 2003 1.25
47 RanBPM contributes to Semaphorin3A signaling through plexin-A receptors. J Neurosci 2006 1.24
48 Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci 2006 1.24
49 Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci 2009 1.22
50 Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol 2011 1.18
51 Anatomical plasticity of adult brain is titrated by Nogo Receptor 1. Neuron 2013 1.18
52 Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci 2006 1.16
53 Response to correspondence: Kim et al., "axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199. Neuron 2007 1.15
54 Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci 2011 1.14
55 Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J Neurosci 2005 1.12
56 Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol 2011 1.12
57 Release of MICAL autoinhibition by semaphorin-plexin signaling promotes interaction with collapsin response mediator protein. J Neurosci 2008 1.12
58 Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis. J Neurosci 2009 1.11
59 Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. J Biol Chem 2006 1.07
60 Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma 2009 1.03
61 Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science 2011 1.03
62 Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc Natl Acad Sci U S A 2012 1.02
63 Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J Neurosci 2012 1.02
64 Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 2010 1.00
65 Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J Mol Med (Berl) 2009 0.99
66 Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain 2012 0.98
67 Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci 2005 0.98
68 Regulating axon growth within the postnatal central nervous system. Semin Perinatol 2004 0.98
69 Nogo and the Nogo-66 receptor. Prog Brain Res 2002 0.97
70 A multi-domain fragment of Nogo-A protein is a potent inhibitor of cortical axon regeneration via Nogo receptor 1. J Biol Chem 2011 0.97
71 Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 2012 0.97
72 Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch Neurol 2009 0.96
73 Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways. Exp Neurol 2012 0.96
74 Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat. Exp Neurol 2006 0.95
75 Nogo-C is sufficient to delay nerve regeneration. Mol Cell Neurosci 2003 0.94
76 PlexinA2 limits recovery from corticospinal axotomy by mediating oligodendrocyte-derived Sema6A growth inhibition. Mol Cell Neurosci 2012 0.92
77 Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage. J Biol Chem 2011 0.91
78 A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem 2004 0.90
79 Regenerating nerves follow the road more traveled. Nat Neurosci 2002 0.90
80 Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice. Curr Alzheimer Res 2007 0.89
81 Diffusion tensor imaging as a predictor of locomotor function after experimental spinal cord injury and recovery. J Neurotrauma 2014 0.87
82 Nogo receptor deletion and multimodal exercise improve distinct aspects of recovery in cervical spinal cord injury. J Neurotrauma 2010 0.86
83 Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells. J Biol Chem 2011 0.86
84 Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion. J Neurotrauma 2014 0.83
85 Functional MRI and other non-invasive imaging technologies: providing visual biomarkers for spinal cord structure and function after injury. Exp Neurol 2008 0.81
86 Neuroscience. Lynx for braking plasticity. Science 2010 0.78
87 Multimodal exercises simultaneously stimulating cortical and brainstem pathways after unilateral corticospinal lesion. Brain Res 2013 0.77
88 Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice. J Comp Neurol 2013 0.77
89 Nogo-A marks motor neuron disease. Ann Neurol 2007 0.76
90 No association between schizophrenia and polymorphisms of the PlexinA2 gene in Chinese Han Trios. Schizophr Res 2007 0.76
91 Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients. Biomarkers 2009 0.75